Serial Number | 87628754 |
Word Mark | ZABBIO |
Filing Date | Friday, September 29, 2017 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, June 29, 2020 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 2, 2019 |
Goods and Services | Diagnostic reagents for scientific or research use; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Reagents for chemical analysis, other than for medical or veterinary purposes; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Reagents for use in scientific apparatus for chemical or biological analysis; Reagents for use in infectious disease research |
Goods and Services | Contraceptive apparatus; Intra uterine contraceptive devices; Contraceptive vaginal rings; Medical apparatus for introducing pharmaceutical preparations into the human body |
Goods and Services | Pharmaceutical research and development; research and development of pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, viral and infectious diseases, cancer, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, sexually transmitted infections including, but not limited to, HIV, HPV, and herpes and hemolytic diseases and disorders; research and development of pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, urological preparations, contraceptives, ophthalmologic preparations, tissue and skin repair preparations and gynecological preparations; research and development of drug delivery devices; medical and scientific research, namely, conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Pharmaceutical research and development in relation to infectious disease prevention and therapy |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, October 5, 2017 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, October 5, 2017 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, October 5, 2017 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | ZabBio, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 92121 |
Party Name | ZabBio, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 92121 |
Event Date | Event Description |
Monday, June 29, 2020 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
Monday, June 29, 2020 | ABANDONMENT - NO USE STATEMENT FILED |
Thursday, November 14, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
Tuesday, November 12, 2019 | EXTENSION 1 GRANTED |
Tuesday, November 12, 2019 | EXTENSION 1 FILED |
Tuesday, November 12, 2019 | TEAS EXTENSION RECEIVED |
Tuesday, May 28, 2019 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, April 2, 2019 | PUBLISHED FOR OPPOSITION |
Wednesday, March 13, 2019 | NOTICE OF PUBLICATION |
Wednesday, February 27, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, February 26, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, February 26, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, February 26, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, January 31, 2019 | NON-FINAL ACTION MAILED |
Thursday, January 31, 2019 | NON-FINAL ACTION WRITTEN |
Friday, January 11, 2019 | LIE CHECKED SUSP - TO ATTY FOR ACTION |
Thursday, January 10, 2019 | ASSIGNED TO LIE |
Thursday, May 17, 2018 | LETTER OF SUSPENSION MAILED |
Thursday, May 17, 2018 | SUSPENSION LETTER WRITTEN |
Tuesday, May 15, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, May 14, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, May 14, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, January 8, 2018 | NON-FINAL ACTION MAILED |
Monday, January 8, 2018 | NON-FINAL ACTION WRITTEN |
Monday, January 8, 2018 | ASSIGNED TO EXAMINER |
Thursday, October 5, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Tuesday, October 3, 2017 | NEW APPLICATION ENTERED IN TRAM |